Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenues:
Product sales, net	$ 6,021	$ 3,706	$ 12,520	$ 7,174
Research and development income	437	109	750	268
Licensing, royalty and other revenue	25	5	66	62
Total revenues	6,483	3,820	13,336	7,504
Costs and Expenses:
Cost of sales	3,580	2,673	7,567	5,248
Selling, general and administrative expenses	1,156	706	2,438	1,386
Product development and research expenses	2,028	805	3,393	1,463
Total costs and expenses	6,764	4,184	13,398	8,097
Operating loss	(281)	(364)	(62)	(593)
Interest expense and other, net	(64)	(39)	(116)	(67)
Net loss	$ (345)	$ (403)	$ (178)	$ (660)
Basic and diluted loss per share (in Dollars per share)	$ (0.01)	$ (0.01)	$ 0.00	$ (0.02)
Weighted average shares of common stock outstanding:
Basic and diluted (in Shares)	47,107,094	43,206,016	46,967,688	43,070,335